Recording Office Visits and Procedures
Proactively addressing the use of electronic recordings can help practitioners avoid misunderstandings, reputational damage, and potential liability.
Search
Jun 05, 2025
Foundation Receives Record Number of Grant Entries for 2025
In the 2025 grant cycle, The Doctors Company Foundation received a record number of Letters of Intent—107 letters were submitted by the March 19 deadline. The Foundation’s grant review committee will now have the challenging task of evaluating those submissions to select a limited number of projects to move forward to the second phase of the grant making process.
From
The Doctor’s Advocate
August 01, 2025, Healthcare Risk Management
DOJ Targeting Healthcare for False Claims Act Enforcement
Federal regulators and law enforcement are looking at healthcare organizations for False Claims Act (FCA) violations. Richard F. Cahill, JD, Vice President and Associate General Counsel at The Doctors Company, provides recommendations for healthcare providers to review their compliance programs to avoid FCA enforcement actions.
Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Artificial Intelligence and the Future of Healthcare
This video series explores how artificial intelligence (AI) will change the future of healthcare.
The Doctors Company Announces $14.3 Million Dividend
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, announced today that it has approved a 2026 premium dividend of approximately $14.3 million, bringing the total of declared dividends to date to $500 million.
Video Nov 18, 2022
What to Expect from Litigation: Dr. Grollo's Perspective
Dennis Grollo, MD, a family physician, describes a malpractice case against him involving a long-time patient and allegations of using an out-of-state pharmacy.
2025 Great Place to Work Certification
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, announced today it has been Certified as a Great Place to Work for the third time. The recognition is based entirely on what current employees say about working at The Doctors Company, with 89 percent of employees saying it’s a great place to work.
The Doctors Company Announces $14.7 Million Dividend
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, announced today that it has approved a 2024 premium dividend of approximately $14.7 million, bringing the total of declared dividends to date to $470 million.
February 26, 2025, STAT News
Are We Adopting AI Scribes Based on…Vibes?
This article examines AI-driven scribe technologies and their marketing claims. It also cites the article "Ambient Listening–Legal and Ethical Issues," in which I. Glenn Cohen, JD; Julie Ritzman, MBA, CPHRM; and Richard F. Cahill, JD, provide a comprehensive analysis of the legal and ethical considerations associated with the use of ambient listening technologies in healthcare settings.
